PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStudy of Ashkenazi Jewish women suggests gene screening rethink

BioNews

Study of Ashkenazi Jewish women suggests gene screening rethink

Published 5 September 2014 posted in News and appears in BioNews 770

Author

Dr Charlotte Warren-Gash

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

All Ashkenazi Jewish women should be screened for high-cancer-risk genetic mutations) from age 30, say scientists behind a study looking at that population....

All Ashkenazi
Jewish women should be screened for high-cancer-risk genetic mutations from age
30, say scientists behind a study looking at that population.

In the
research, women who tested positive for dangerous mutations in the BRCA1 and
BRCA2
genes - which occur in relatively high frequency among Ashkenazi Jews - had high rates of breast and ovarian cancer, even with no
family history of the disease.

Speaking to The New York Times, Dr Ephrat
Levy-Lahad, senior author of the study and director of medical genetics at
Shaare Zedek Medical Center in Israel, voiced her support for BRCA screening
being offered as a universal test. 'We should be screening
people who are still healthy at a stage when we can prevent the disease',
she said.

In Israel, current
practice is to screen women for these mutations only if they have breast or
ovarian cancer or have a strong family history of the disease. Identifying
carrier status earlier can allow women to take preventive measures such as
mammography, physical examination, removal of the ovaries and fallopian tubes
or risk-reducing mastectomy.

In the study,
which is published in the journal PNAS, researchers screened over 8,000 healthy Ashkenazi Jewish men from out-patient
clinics for mutations in the BRCA1 and BRCA2 genes and then tested these men's female
relatives for the mutations. In this way 211 women with mutations were
identified. Of the women who reached aged 60, 60 percent of BRCA1 carriers and
one third of BRCA2 carriers had developed breast or ovarian cancer, although half
reported no family history of cancer.

Among
Ashkenazi Jews, 11 percent of breast cancers and 40 percent of ovarian cancers
are linked to mutations in the BRCA1 and BRCA2 genes. Professor Mary-Claire
King
from the University of Washington, joint senior author of this study, helped
discover the BRCA1 gene in 1990.

Some
clinicians, however, are sceptical about the benefits of universal screening. Dr
Susan Domchek, from the Basser Research Center for BRCA at the University of
Pennsylvania, told the New York Times: 'I don't think this
resolves the question of what the risk is to someone with no family history and
a mutation'.

Speaking
about preventative removal of healthy breasts and ovaries Dr Domheck said: 'These
[procedures] are not trivial. They have potential to cause harm'.

The deputy chief medical officer
of the American Cancer Society, Dr Leonard Lichtenfeld, noted that the results
were thought-provoking but would have to be discussed extensively before there
was any change to screening practice. 'People who think they
should be tested really need to be appropriately counselled about the potential
benefits and potential risks', he told The New York
Times.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 September 2014 • 3 minutes read

'Offer breast cancer risk gene screening to every 30-year-old woman', says scientist who discovered BRCA1

by Dr Rachel Montgomery

A leading scientist involved in the identification of the BRCA1 gene mutation has recommended that genetic screening of the BRCA genes should be routinely offered to all women aged 30 years or over....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
27 May 2014 • 4 minutes read

Breast cancer: breaking the chain

by Dr Ann Robinson

As a GP in North London, I see the ravaging effects of breast cancer in young women. Each patient sticks in my mind as their illness traumatises the whole family...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2013 • 2 minutes read

Breast cancer risk may still be higher despite BRCA-negative test results

by Dr Charlotte Warren-Gash

Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 February 2013 • 3 minutes read

'Marry out?' Some surprising consequences of genetic disease risk among Ashkenazi Jews

by Dr Jessica Mozersky

Ashkenazi Jews have historically been an endogamous population. Marrying within the group remains important to many Jews because endogamy is seen as one way to preserve Judaism and ensure the survival of future generations. In the wake of the Holocaust, and amidst a steadily decreasing Jewish population, Jewish survival has great cultural relevance...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Discrimination fears over breast cancer test

by BioNews

Some Jewish women could face discrimination over access to tests for hereditary breast cancer, the Scientist magazine reports. Geneticists at a meeting held last week said that changes made to a patent relating to the BRCA2 gene, owned by US firm Myriad Genetics, could mean that women of Ashkenazi Jewish...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Canadian cancer centre reports 'Angelina effect'

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856